We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Top Buys

1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$2.75M
2
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$2.47M
3
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$2.28M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2M
5
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$1.99M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131K
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$113K
3
VUG icon
Vanguard Growth ETF
VUG
+$104K
4
VT icon
Vanguard Total World Stock ETF
VT
+$103K
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$97.9K

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
301
Seagate
STX
$178B
$13K 0.01%
235
– –
BCPC
302
Balchem Corp
BCPC
$5.24B
$13K 0.01%
135
– –
BIV icon
303
Vanguard Intermediate-Term Bond ETF
BIV
$29.1B
$12K ﹤0.01%
147
-112
-43% -$9.05K
BUD icon
304
AB InBev
BUD
$155B
$12K ﹤0.01%
115
– –
HEDJ icon
305
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
$12K ﹤0.01%
366
– –
NVS icon
306
Novartis
NVS
$294B
$12K ﹤0.01%
173
– –
TJX icon
307
TJX Companies
TJX
$170B
$12K ﹤0.01%
252
– –
WMB icon
308
Williams Companies
WMB
$89.4B
$12K ﹤0.01%
459
-139
-23% -$3.67K
QVCGA
309
DELISTED
QVC Group Inc Series A
QVCGA
$12K ﹤0.01%
+12
New +$13.3K
BCS.PRD.CL
310
DELISTED
Barclays Bank Plc
BCS.PRD.CL
$12K ﹤0.01%
450
– –
AMBA icon
311
Ambarella
AMBA
$2.75B
$11K ﹤0.01%
275
– –
BNDX icon
312
Vanguard Total International Bond ETF
BNDX
$82.2B
$11K ﹤0.01%
203
-366
-64% -$20K
BX icon
313
Blackstone
BX
$155B
$11K ﹤0.01%
351
+4
+1% +$127
CSCO icon
314
Cisco
CSCO
$443B
$11K ﹤0.01%
262
+58
+28% +$2.53K
CSD icon
315
Invesco S&P Spin-Off ETF
CSD
$218M
$11K ﹤0.01%
+204
New +$11.1K
ES icon
316
Eversource Energy
ES
$28B
$11K ﹤0.01%
188
– –
GIS icon
317
General Mills
GIS
$20.3B
$11K ﹤0.01%
242
– –
GSK icon
318
GSK
GSK
$103B
$11K ﹤0.01%
223
-98
-31% -$4.94K
INGR icon
319
Ingredion
INGR
$6.44B
$11K ﹤0.01%
100
+90
+900% +$10.6K
JAZZ icon
320
Jazz Pharmaceuticals
JAZZ
$15.5B
$11K ﹤0.01%
62
– –
PNC icon
321
PNC Financial Services
PNC
$101B
$11K ﹤0.01%
83
-15
-15% -$2.19K
REGN icon
322
Regeneron Pharmaceuticals
REGN
$70.8B
$11K ﹤0.01%
33
– –
RTX icon
323
RTX Corp
RTX
$262B
$11K ﹤0.01%
145
– –
TFCFA
324
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$11K ﹤0.01%
219
+5
+2% +$198
EPD icon
325
Enterprise Products Partners
EPD
$83B
$10K ﹤0.01%
362
– –
11 12
13
14 15

Similar funds

VWM
Venturi Wealth Management Austin, Texas $2.22B AUM 24.65% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.23B AUM 15.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.